Author: Asia PEVC

AppsFlyer Launches Xpend to Provide Marketers Accurate Cost Data at Scale in One Holistic Platform

Xpend ties aggregate cost and attribution data together so marketers can quickly and effectively optimize marketing performance and accurately calculate their true ROI

AppsFlyer, the global attribution leader, today announced the launch of Xpend, the company’s new cost aggregation product that supports complex schema and data mapping to help alleviate the pain points marketers face due to fragmented cost data. With the industry shifting towards a more aggregate way of measuring marketing efforts, the importance of having an accurate, complete, and actionable cost aggregation solution has become paramount. Xpend covers 100% of marketers’ spend data from any source, and provides access to granular data enabling them to act fast on their spending goals, accurately optimize ad spend, and ultimately make smarter and more informed decisions.

“Over the past few years, we’ve worked with thousands of customers and partners measuring tens of billions of dollars in ad spend through our cost aggregation product. Everything we learned was used to create its next generation – Xpend,” said Gal Brill, General Manager – ROI360, AppsFlyer. “We see this product as part of a holistic approach to help our advertisers and partners keep their marketing stack working seamlessly. “Providing aggregate cost data via APIs has become more important than ever before. Through years of experience working with performance marketers, we’ve built Xpend to solve the data aggregation and normalization challenges that marketers face today. AppsFlyer is well known for providing reliable and accurate attribution data; tying in cost is only a natural next step.”

Marketers are familiar with the tedious setbacks associated with fragmented data such as manually entering in weekly spend reports for hundreds of channels and sources, pulling together endless spreadsheets, filling in missing gaps, and correcting wrong data. As marketers strive to keep up with growing scale and data complexity, Xpend allows them to access all of their data in one innovative in-house solution to accurately optimize their marketing spend.

With industry updates focused around privacy and security ahead, using cost data tied to attribution links alone may no longer be considered a reliable solution on its own. This is why combining privacy centric attribution with aggregating cost data directly through API integrations with partner networks is a critical solution for marketers.

“At the core of our customer-centric strategy is keeping our ear to the ground: listening and responding to the industry’s pulse. We should know what marketers want and need before they even realize it,” said Ronen Mense, APAC President & Managing Director, AppsFlyer.

The exponential expansion of data, coupled with the challenge of managing thousands of channels and networks, has become the number 1 pain point for every marketer. On top of this, the inclusion of currencies has also created an expensive and wasteful problem of information overload. From that point on, we knew we had to develop an industry-first solution.

With Xpend, all of these data points are being pulled into one place, seamlessly housing attribution and cost under one control center. This latest AppsFlyer product offering delivers an accurate, mobile-first compatible, and fully optimized cross-channel experience.”

Xpend provides marketers a comprehensive way to access all cost data and streamline it into an ETL (Extract, Transform, Load) process, which aligns various schema of data into a single model that makes the data easy to aggregate, analyze, and optimize. Additionally, Xpend is integrated with 60+ APIs, including Facebook, Google, AppLovin, and recently added Twitter & Tencent Marketing Solutions.

For more information on Xpend, please visit https://www.appsflyer.com/cost-aggregation/.

About AppsFlyer

AppsFlyer, the global attribution leader, empowers marketers to grow their business and innovate with a suite of comprehensive measurement and analytics solutions. Built around privacy by design, AppsFlyer takes a customer-centric approach to help 12,000+ brands and 7,000+ technology partners make better business decisions every day. To learn more, visit www.appsflyer.com.

Media Contacts
Ishina Sakhrani
PRecious Communications on behalf of AppsFlyer
appsflyer@preciouscomms.com
+65 6303 0567

Press Contact For AppsFlyer in APAC
Nico Marco
nico.marco@appsflyer.com

Zijin Mining held the Sixth Science and Technology Symposium to Comprehensively Build Technology-led Global Competitiveness

On 9th September 2020, Zijin Mining convened the Sixth Science and Technology Symposium successfully. Mr. Chen Jinghe, the Chairman of Zijin Mining, put forward the science and technology manifesto of “promoting the Company’s global leaping development with scientific and technological innovation as the driving force”, indicating that Zijin Mining will fully establish technology-led global competitiveness.

The symposium was attended by distinguished guests, including Mr. Peng Qiming, President of China Mining Association; academicians of Mr. Zhang Wenhai, Mr. Sun Chuanyao, Mr. Qiu Guanzhou, Mr. Cai Meifeng, Mr. Mao Jingwen, Mr. Lin Jun, Mr. Chai Liyuan and Mr. Xu Zhenghe; Mr. Zhang Yongtao, Vice President of China Gold Association; Mr. Zhou Shiju, Deputy Director of the Science and Technology Department of Fujian Province; municipal and county-level officials of Mr. Zhang Guowang, Mr. Xie Haibo, Mr. Fu Cangrong and Mr. Wang Bo; as well as representatives from Guidance Center for Mineral Exploration Technology of the Ministry of Natural Resources, Department of Natural Resources of Fujian Province, Fujian Association for Science and Technology, Fuzhou University, Jimei University, Kunming University of Science and Technology, Jiangxi University of Science and Technology, research and design institutions at home and abroad as well as cooperative units. Mr. Zou Laichang, President of Zijin Mining, presided the opening ceremony of the symposium. Mr. Jiang Kaixi, chief engineer of Zijin Mining, reported on the scientific and technological work.

Technology creates and recreates Zijin Mining. For more than 20 years, Zijin Mining has sticked to scientific and technological innovation as its primary driving force, becoming one of the few multinational mining companies around the globe equipped with autonomous system technology and engineering management capabilities, with relatively well-established scientific research system and practice platform. Zijin Mining pioneered the mining project management model of “integrating five ore treatment processes into one” and realised coordinated research and full process control on five procedures of geological prospecting, mining, processing, refining and environmental protection, achieving the maximisation of economic and social benefits and promoting the continuous implementation of management and technological innovation concepts. From learning to leading, Zijin Mining has formed the core competitiveness and comparative advantages of the enterprise, which have strongly supported the rapid development of various businessess of the Company.

Mr. Chen Jinghe, the chairman, delivered a speech at the opening ceremony. He highlighted that “scientific and technological innovation creates Zijin” is a lively depiction of Zijin Mining’s development history in the past 20 years. Scientific and technological innovation has become a powerful driver for the Company’s high-speed development, and scientific and technological workers are the pillars forming the Company’s core competitiveness.

Looking ahead to the future, Mr. Chen Jinghe pointed out that uncertainty in the current global politics and economy increases. However, position of the mining industry, which is a fundamental industry, has not changed and still remains relatively stable. Furthermore, owing to substantial rise in investment costs and costs of obtaining mineral resources, the prices of mineral resources are likely to stand firm. Zijin Mining is determined to become a tier-one metal mining company with global competitiveness, which is the glorious mission and vision of the Company. The Company must speed up the conversion of advantage in resources into advantages in products and efficacy, which is the most crucial and core task at present.

Firstly, Zijin Mining will drive for scientific and technological innovation with a global vision and new mindset. The Company will pursue scientific and technological innovation from an even higher starting point, and strive for excellence above international standards. Its project management model of “five ore treatment processes into one”will be applied and promoted more extensively. Efforts will be made to further uncover super-large deposits of significant market value, and achieve technological breakthroughs in the use of deep shafts for efficient, cost-saving and safe mining. In addition, research and application of eco-friendly processing and refining technology will be focused on to realise the goal of green and eco-friendly development in both of the Company’s domestic and overseas projects.

Secondly, Zijin Mining will emphatically develop a highly fitting, globalised mechanism for operation and management which is supported by science and technology. Treating science and technology as its most important support and guidance in the pursuit for globalisation, the Company will push for deeper reforms in a steady manner. It will accelerate informatisation and intellectualisation of mines, and drive for reforms in quality and efficiency. It will also remain committed to a new path for innovation which is created by its own and bears unique Zijin characteristics, as well as attaining breakthroughs in core and critical technology in shorter timeframe. To live up to its determination of creating an open environment for scientific and technological innovation, the Company will promote exchanges and cooperation with external parties and join forces with various sectors to achieve powerful scientific and technological developments. Furthermore, in order to expeditiously build a new talent base with technical expertise, the Company will reach out globally to explore for acquisition of, or cooperation with high-tech companies that have a strong talent powerhouse.

Thirdly, Zijin Mining will formulate globalised, pragmatic talent development policies with Zijin characteristics. The Company will introduce advanced, veteran and outstanding talents in the science and technology field and young elites from around the world. Leveraging on its various projects across the world, the Company will encourage talented employees to work at the “frontline of the battlefields” to achieve mutual growth with Zijin Mining and realise their personal value. Taking value creation and market standards as the criteria for assessment, it will accelerate the formulation of a global, value-creation focused talent development strategy.

Fourthly, a global Zijin culture will be developed with full efforts. Having strong faith in its own culture, the Company will seek integration with the excellent culture of the localities where its projects operate, weave Zijin Mining’s excellent corporate culture and core values deeply into the fabrics of the enterprise, insist on the core value of mutual development, and, in the course of developing its business, allow its employees the opportunities to realise their personal strength as well as benefit the countries, communities and business partners that are relevant to the Company’s operations.

Mr. Zhang Guowang, Vice Secretary to the municipal Party Committee and acting mayor of Longyan City, and Mr. Zhou Shiju, Deputy Director of the Science and Technology Department of Fujian Province, delivered warm and robust speeches at the symposium. They congratulated the successful convention of the symposium, fully recognised Zijin Mining’s achievements in scientific and technological innovation, and provided invaluable advice and guidance on Zijin Mining’s future implementation of scientific and technological innovation strategies, as well as the importance of scientific and technological innovation in leading future development.

At the symposium, commendations were given to Zijin Mining’s outstanding leaders, team members, workers and collaborators who specialise in the field of science and technology, as well as the outstanding projects and their representatives. The symposium was broadcasted worldwide online.

Edvantage Group (0382) Announced Positive Profit Alert for the Third Time Since its Listing

The core net profit for FY2020 is being expected to increase by no less than 30% YoY

Edvantage Group Holdings Limited (“Edvantage Group” or the “Group”, stock code: 0382.HK), the largest private higher education group in Guangdong-Hong Kong-Macau Greater Bay Area (the “Greater Bay Area”), is pleased to announce positive profit alert for FY2020, expecting to record an increase of no less than 30% YoY in the core net profit of the Group for the 12 months ended 31 August 2020 (the “Period under Review”). This is the third time that the Group has released a positive profit alert after its listing.

The number of students and average tuition fee in the 2019/20 school year both have increased
The Group is benefited from the national policy to support the development of the Greater Bay Area and the pressing crave for business talents in the Greater Bay Area. At the same time, the Group’s Huashang education brand and school-running capabilities have been recognized and sought after by the society. Given the popularity of international school-running models of its schools, during the Period under Review, the number of students and the average tuition fee of the two Chinese schools of the Group, Huashang College Guangdong University of Finance and Economics and Guangzhou Huashang Vocational College, increased compared with the same period last year. In addition, as the new Sihui and Xinhui campus have been put into use one after another, it is expected that the organic growth of the Group will become stronger day by day, thereby ensuring the continued improvement of the Group’s performance.

Tuition fees for new students of the 2020/21 school year recorded impressive growth
The registration of freshmen for the 2020/21 school year has been delayed due to the COVID-19 epidemic. It is still in the admission stage and registration progress is expected to be announced in October. Regarding the tuition fees for new students in the 2020/21 school year, the range of tuition fees for the new students in the 2020/21 school year of the Group’s institutions has increased considerably. The higher fees reflect the Group’s continuous improvement in school quality. The tuition fees for new students taking undergraduate courses range from RMB 28,000~43,800, recording an increase of RMB 1,000~4,000 YoY; the tuition fee range for new students of junior college to bachelor’s degree transfer programs is RMB 27,000~33,000, recording an increase of RMB 2,000~3,200 YoY; the tuition fee range for new students taking junior college courses is RMB 16,500~28,000, representing a general adjustment to increase by RMB 1,000 YoY. It is estimated that the Group’s average tuition fee for undergraduates in the 2020/21 school year will be close to RMB 30,000, and the average tuition for junior colleges will be approximately RMB 17,000.

About Edvantage Group Holdings Limited
Edvantage Group Holdings Limited (“Edvantage Group” or the “Group”, stock code: 0382.HK) is the largest private higher education group in the Greater Bay Area, and an early mover in education sector in pursuing international expansion. The total number of student enrolments of the Group were 35,444 and the Group owns 5 schools in both China and overseas as of 31 May 2020.

In China, the Group currently operates 2 private higher education institutions in Guangdong Province, namely undergraduate colleges Huashang College Guangdong University of Finance and Economics and Guangzhou Huashang Vocational College, featuring business courses (such as accounting, finance, economics and business English) as the strategic curriculum; In overseas, the Group operates a private vocational education institution named Global Business College of Australia (“GBCA”) authorised by Australian Skills Quality Authority (ASQA) in Australia, offering vocational education courses and non-formal short-term courses. GBCA is the first Chinese international education institution approved by the Australian government. In December 2019, the Group has also acquired a private vocational education institution in Singapore, that is, Edvantage Institute (Singapore) (“EIS”) (formerly known as NYU Language School), which has been accredited as EduTrust by the Education Department of Singapore. It is qualified to offer internationally-recognised courses and accept local and overseas students in Singapore. Moreover, the Group established a higher education institution Edvantage Institute Australia (“EIA”), which is granted by the Tertiary Education Quality and Standards Agency (TEQSA) in the first quarter of year 2020, and qualified to accept students, offer and award undergraduate and master degrees. It is expected to start students recruitment in the first quarter of year 2021.

Moonstake and Infinito Wallet enter into partnership to enhance the staking ecosystem and scale the Defi projects

We are pleased to announce that Moonstake and Infinito have entered into a strategic partnership to bring the staking economy to the hands of people. Infinito Wallet will integrate with Moonstake to enable staking for all assets operated in Moonstake’s staking pools.

This partnership will open a door for Infinito Wallet users to directly stake through Moonstake staking pools and earn rewards without any hassle process. This strategic partnership will create the synergies by jointly driving staking activity and accelerate industry adoption of the staking ecosystem. Besides, both parties will conduct joint research on DeFi products.

Moonstake is an advanced technology company with specific focuses on blockchain and staking technologies to build Asia’s Biggest Staking Network. Moonstake was established to develop a staking pool protocol to satisfy increasing demands in regional and global blockchain markets. Signature products include Moonstake Web Wallet along with Moonstake Mobile Wallet (iOS/Android) enabling full staking functions and to be an all-in-one gateway for users to maximize the usage and potential of cryptocurrencies. Currently, Moonstake’s staking pool supports Cosmos, IRISnet, Ontology, Harmony, Cardano, QTUM and Tezos thereby providing current users with the flexible option to adopt staking purposes.

Our strategic partner, Infinito Wallet unlocks the power of investing and trading of top cryptocurrencies. It provides a safe place for every user to manage and grow their crypto wealth, and enjoy decentralized finance. Infinito Wallet has been growing with over 30,000 active users globally and millions of USD in cryptocurrencies being managed on the wallet by the user community. Infinito Wallet is frequently ranked amongst the best wallets for crypto communities in the world such as one of the best wallets for EOS, ADA, ETH, ONT, best crypto Wallet & DAPP Browser and more.

Infinito Wallet was one of the first mobile wallets on the market to support services and assets on BinanceChain, ADA, EOS and many more top-tier blockchain protocols. Top leading blockchain service providers and various protocol have joined Infinito ecosystem to offer benefits and advanced features to the community, and boost the expansion of the crypto ecosystem such as Binance, Tomochain, Neo, EOS, Ontology, IRIS, IOHK for Cardano, Holdex, Kybernet work, FIO with over 50+ leading Dapps and services.

Furthermore, dApps browser for interacting with the DeFi ecosystem within the wallet by providing nativie exchange feature with Changelly exchange, peer-to-peer way to buy Bitcoin with 167 fiat currencies through over 300 payment methods at great prices with Paxful (peer-to-peer BTC market place), buy crypto with debit & credit card with the best rate with Simplex and more. Through the expansion of its partner network, Infinito Wallet wants to make crypto investment easy for mass adoption.

As a leading blockchain tech provider, Infinito has also released the Infinito Blockchain Platform (IBP for short), a comprehensive all-in-one blockchain platform for businesses, developers and academia to seamlessly make use of a wide variety of blockchain-based functionality in one place. It enables easy development of decentralized apps using APIs. Businesses can also choose from various turnkey SaaS, modules, services, and solutions periodically to their needs. Infinito invites blockchain developers and technology companies around the world to aboard IBP and create a value-driven blockchain ecosystem through which anyone utilizing, or looking to utilize blockchain can succeed.

Mitsuru Tezuka, CEO at Moonstake says:
“Infinito Wallet offers safe and easy access to various blockchain-powered services. With the strong collaboration between Moonstake and Infinto, both of our ecosystems can provide the best services to both the community and entire blockchain industry, We are looking forward to our upcoming integration.”

Jack Nguyen, Director at Infinito Wallet says:
“We are excited to partner with Moonstake, which is committed to creating Asia’s biggest staking pool network so Infinitors and Moonstake users can enjoy a perfect blockchain and staking experience. We believe that this partnership further boosts the Defi ecosystem and grows the wider blockchain community together.”

About Moonstake
Moonstake was recently established to develop a staking pool protocol to satisfy increasing demands in regional and global blockchain markets. Moonstake develops a staking pool protocol and provides business services through partners and companies.

Moonstake aims to create the largest staking pool network in Asia, a robust environment for the cryptocurrency holders is one of its missions. Establishing a clear partnership roadmap with Moonstake represents another significant milestone for continuing to strengthen ties with leading platforms across Asia’s burgeoning Distributed Ledger Technology (DLT) ecosystem. partnership has been announced with Emurgo, Ontology and NEO to boost staking adoption, Binarystar, Japan’s biggest blockchain hub, OIO Holdings Limited (SGX: OIO), a Singapore Catalist-Listed company. Industry’s reputed advisors, such as Lisk and Lawrence Lim of RAMP DEFI support Moonstake’s innovative journey. https://www.moonstake.io/

About Infinito Wallet
Infinito Wallet is a leading decentralized finance wallet for crypto users, serving as a gateway for users to maximize usage and potential of their cryptocurrencies. Being a safe place for people to start investing and earning money with cryptocurrencies, Infinito Wallet provides a seamless and educational onboarding process for newbies as well as a comprehensive feature list that enables people to buy, sell, trade, stake, lend and secure their crypto fund. The goal Infinito Wallet wants to achieve is to make cryptocurrencies easy for people to adopt and enjoy. https://www.infinitowallet.io/

Pacific Green Marine Technologies, Inc. Installs its 100th Envi-Marine(TM) Exhaust Gas Cleaning System

Pacific Green Technologies, Inc. (the “Company” or “PGTK”, (OTCQB:PGTK) announces that it has successfully installed its 100th ENVI-Marine(TM) exhaust gas cleaning system.

PGTK’s industry leading ENVI-Marine(TM) exhaust gas cleaning systems have now been installed on more than 40 different ship types, including containers, bulk carriers and oil tankers. The installations have been completed predominantly in China shipyards in conjunction with PGTK’s joint venture partner, PowerChina SPEM.

Scott Poulter, PGTK’s Chief Executive commented: “We are very proud to have reached this milestone in our marine division. Although the industry has been in turmoil so far in 2020 with oil price pressure and the consumer demand effects of Covid-19, we have started to see positive signs with a significant increase in enquiries over the past few months for our ENVI-Marine(TM) System.”

PGTK has continued to expand its technologies through its acquisition of ENGIN in December 2019 so that its portfolio now includes Concentrated Solar Power (CSP) and Water Desalination. PGTK continues to actively seek complementary technologies to add to its Cleantech portfolio.

Scott added: “Pacific Green is now targeting specific industries and sectors where its technology enhances the growing trend for Cleantech solutions. As well as having the capability and resources to carry out whole large scale projects, Pacific Green will continue to develop and produce new cutting edge products as we expand into new areas.”

PGTK’s joint venture with PowerChina SPEM, one of the world’s largest engineering, procurement and construction companies with annual revenues of around $50 billion, combines elite technical expertise with unrivalled production capabilities in China ensuring PGTK can scale efficiently in each industry sector.

PGTK will continue to adhere to a high-quality development strategy, implement improved processes in all disciplines, and provide state of the art professional and efficient products and services for its customers.

About Pacific Green Technologies, Inc.

Pacific Green Technologies Inc. is focused on addressing the world’s need for cleaner and more sustainable energy. The Company’s strategy is to build through organic development and acquisition, a portfolio of patented competitive cutting edge technologies designed to meet increasingly stringent environmental standards. For more information, visit PGTK’s website: www.pacificgreentechnologies.com

About POWERCHINA SPEM Co. Ltd

POWERCHINA SPEM is a subsidiary of POWERCHINA, the largest power equipment manufacturer in the PRC. With abundant resources, expertise, strong manufacturing capacity, domestic sales channels and rich experience, POWERCHINA SPEM is in a strong position to deploy PGTK technology throughout the PRC.

Notice Regarding Forward-Looking Statements:

This news release contains “forward-looking statements,” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the ongoing effects of the pandemic on delays and orders regarding Pacific Green’s emission control system, potential business developments in India and future interest in our solar and desalination technologies.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, general economic and political conditions, the continuation of the JV with POWERCHINA SPEM, and the ongoing impact of the pandemic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:
Scott Poulter, Chairman & CEO
Pacific Green Technologies
T: +1 (302) 601-4659

SOURCE: Pacific Green Technologies, Inc.

Redsun Services Acquires Chuzhou Yurun for RMB36.7 Million

Further Expands Scope of Business Operations

Redsun Services Group Limited (“Redsun Services” or the “Group”), a fast-growing comprehensive community services provider focusing on the Yangtze River Delta, has today announced the acquisition of 51% equity interest in Chuzhou Yurun Property Management Company Limited (“Chuzhou Yurun”) at a consideration of RMB36.7 million, the Group’s first acquisition since its listing in July.

Chuzhou Yurun is principally engaged in the provision of property management services in Jiangsu Province, Anhui Province and Hunan Province in the PRC. As at 7 September 2020, the aggregate GFA of properties under management by Chuzhou Yurun is approximately 4.2 million sq.m. The latest acquisition will enable the Group to further expand its scale and business scope, thereby allowing the Group to reduce management costs, improve management efficiency and achieve economies of scales in the future. For the six months ended 30 June 2020, Chuzhou Yurun’s profit reached RMB3.4 million. After the completion of the acquisition, Chuzhou Yurun will become a subsidiary of Redsun Services, hence immediately contributing to the Group’s profitability.

The Group managed to complete its first acquisition project in just two months after listing in July 2020, a proof of the Group’s consistently high execution ability. Redsun Services will take this acquisition as the first step, and will continue to seize strategic investments and acquisition opportunities in the future, so as to further expand the scale of business operations to enhance competitiveness.

About Redsun Services Group Limited
Established in Nanjing in 2003, Redsun Services Group Limited is a fast-growing comprehensive community service provider focusing on the Yangtze River Delta. With a vision of “making lives warmer,” the Group strives to continuously “provide high-quality services for customers with sincerity.” The Group has also established the regional leading position in the property management market of Jiangsu province and is well-recognized nationwide. The Group was recognized as one of the Top 100 Property Management Companies by CIA for four consecutive years since 2017 and ranked 25th among the 2020 Top 100 Property Management Companies in terms of overall strength.

Avance Clinical Client Immunic, Inc. Announced Dosing of First Healthy Volunteer in Phase 1 Clinical Program of IMU-856, Targeting Restoration of Intestinal Barrier Function

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the news that its client Immunic Therapeutics has announced dosing of the first healthy volunteer in the company’s phase 1 clinical program of IMU-856, an novel treatment for patients suffering from gastrointestinal diseases, including diarrhea-predominant irritable bowel syndrome, ulcerative colitis and Crohn’s disease.

Immunic Therapeutics (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company developing selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases.

According to the public announcement released by Immunic Therapeutics on 20 August 2020:

> IMU-856, an orally available, small molecule modulator, serves as a transcriptional regulator of intestinal barrier function. Based on preclinical data, the compound appears to represent a novel and potentially paradigm-shifting approach to the treatment of gastrointestinal diseases by potentially restoring intestinal barrier function while maintaining immunocompetency.

> Immunic’s Australian subsidiary, Immunic Australia Pty Ltd., received approval from the Bellberry Human Research Ethics Committee in Australia to conduct a phase 1 clinical trial of IMU-856 under the Clinical Trial Notification (CTN) scheme of the Australian Therapeutic Goods Administration (TGA). The phase 1 clinical program includes single and multiple ascending dose parts in healthy volunteers. Subsequently, Immunic also plans to extend this program to assess biomarker, safety and drug trough levels in patients with diarrhea-predominant irritable bowel syndrome, ulcerative colitis and Crohn’s disease.

Hella Kohlhof, Ph.D., Chief Scientific Officer of Immunic, noted, “Current treatments for many gastrointestinal conditions focus on inhibiting inflammation and do not directly address impaired intestinal barrier function. In contrast, IMU-856 appears to have a unique targeted ability to strengthen and thereby normalize this function, potentially avoiding the bacterial triggers which can occur when the intestinal barrier is impaired. Moreover, because this approach appears to avoid any detrimental effects on the immune system, we believe that IMU-856 has the potential to change the treatment paradigm for gastrointestinal diseases.”

Avance Clinical Chief Scientific Officer Gabriel Kremmidiotis PhD, BSC Hon said, “We consider ourselves fortunate to be working with Immunic on this exciting project. IMU-856 is the second compound that Immunic has selected Avance Clinical as their CRO. Our engagement in these projects has been from early planning, study design, preparation of the investigator brochures and clinical trial protocols. Working with the Immunic team and the Bellberry Human Research Ethics Committee, we have been able to design clinical trials which include careful data informed adaptive elements aimed at expediting the transition of these promising products from healthy volunteers to the patient populations.”

See full announcement here: https://tinyurl.com/y5rvh7fa

About Immunic, Inc.

Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis. Immunic is developing three small molecule products: its lead development program, IMU-838, is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH and exhibits a host-based antiviral effect; IMU-935 is an inverse agonist of RORrt; and IMU-856 targets the restoration of the intestinal barrier function. On August 2, 2020, Immunic announced positive top-line results from its phase 2 EMPhASIS trial of IMU-838 in patients with relapsing-remitting multiple sclerosis, reporting achievement of both primary and key secondary endpoints with high statistical significance, indicating activity for IMU-838 in this indication. IMU-838 is also in phase 2 clinical development for ulcerative colitis and COVID-19, with an additional phase 2 trial considered in Crohn’s disease. An investigator-sponsored proof-of-concept clinical trial for IMU-838 in primary sclerosing cholangitis is ongoing at the Mayo Clinic. For further information, please visit: www.imux.com.

About Avance Clinical

Australia’s Avance Clinical has more than 20-years of experience and is now one of Australia’s leading Contract Research Organizations. Avance Clinical facilitates quality drug development by aligning people, skills, and expertise in the pursuit of drug development for a healthier world.
Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.
Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialized patient groups. Visit http://www.avancecro.com for more information.
Other benefits include:
1. The Government R&D grant means up to 43.5% rebate on clinical trial spend
2. Telehealth pivot during COVID-19 pandemic – speed and continuity
3. Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks
4. No IND required for clinical trials
5. Full GMP material is not mandated for Phase I clinical trials
6. Established clinical trial environment with world-class Investigators and sites
7. Established healthy subject databases and specialized patient populations
8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care
9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research
10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia’s counter-flu and allergy seasons

Media Contact:
media@avancecro.com
Chris Thompson

Greenbriar Capital Corp Reports $2,771,759 or $0.12 per Share of Net Income in Q2 2020

Greenbriar Capital Corp. (TSXV: GRB) (OTC Pink: GEBRF) (“Greenbriar”) is pleased to announce that it has earned net income of $2,771,759 or $0.12 per share for the three (3) months ended June 30, 2020. The unaudited Financial Statements and the respective Management Discussion and Analysis are available for viewing at www.sedar.com.

About Greenbriar Capital Corp

Greenbriar is a leading developer of renewable energy and sustainable real estate. With long-term, high impact, contracted sales agreements in key project locations and led by a successful, industry-recognized operating and development team, Greenbriar targets deep valued assets directed at accretive shareholder value. Greenbriar and its advisors have closed over $180 Billion in renewable energy projects since 2003.

ON BEHALF OF THE BOARD OF DIRECTORS
“Jeff Ciachurski”
Jeffrey J. Ciachurski
Chief Executive Officer and Director

The TSX Venture Exchange has not reviewed and does not accept responsibility for the accuracy or adequacy of this release. Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release may contain forward-looking statements. All statements, other than statements of historical fact, constitute “forward-looking statements” and include any information that addresses activities, events or developments that the Company believes, expects or anticipates will or may occur in the future including the Company’s strategy, plans or future financial or operating performance and other statements that express management’s expectations or estimates of future performance.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/63121

AI Startup Deep Longevity Launches with Series A Financing and New AI System to Tackle Aging-Related Diseases

Deep Longevity, a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging, came out of stealth today from Insilico Medicine with financing from prominent investors worldwide, the launch of the first AI system on the market for aging-related biomarker development, and collaboration with Human Longevity Inc. (“HLI”). Led by ETP Ventures and Human Longevity and Performance Impact Venture Fund (“HLPIVF”), the investment round includes participation from BOLD Capital Partners, Longevity Vision Fund, Oculus co-founder and former chief software architect Michael Antonov through Formic Ventures, and LongeVC. Other undisclosed investors include celebrity investors in artificial intelligence and some of the most prominent U.S. biotechnology investors. Deep Longevity spins out of Insilico Medicine, the AI for drug discovery company recognized for its breakthroughs in generative chemistry, and generative biology.

Deep Longevity has developed a new AI system that can predict an individual’s biological age significantly more accurately than conventional methods, paving the road to discover what biological culprits drive aging-related diseases, including COVID-19. In the company’s first partnership, Deep Longevity will deploy its technology in a collaboration with Human Longevity, the genomics-based, health intelligence leader with the world’s largest database of sequenced genomes and phenotypic information.

“Over the past few years, our team made several discoveries in the field of deep learning for longevity research in both biomarkers of aging and geroprotector discovery,” said Alex Zhavoronkov, PhD, founder and CEO of Deep Longevity. “Deep Longevity will translate these discoveries into the new industry of longevity management and medicine providing longevity as a service. To enable early access to these technologies we partnered with the most prominent concierge longevity practice, Human Longevity. We are happy to announce this round of funding provided by the top experts in longevity, biotechnology, and artificial intelligence. We will help power their longevity ecosystem with a standardized set of aging and longevity biomarkers.”

Building upon several years of published and patented R&D, Deep Longevity’s team of scientists and AI researchers invented the industry’s first-ever aging clocks using deep neural networks. Analyzing millions of anonymized samples from multiple data types – from blood biochemistry, cell count, protein-coding genes to gut bacteria – the team identified aging-related biomarkers for diseases like diabetes, sarcopenia and NASH, and has developed the industry’s broadest portfolio of deep learning-based aging clocks.

“The longevity industry is rapidly evolving and is likely to become the largest industry on the planet,” said Wei-Wu He, PhD, MBA, executive chairman of Human Longevity. “At Human Longevity we are dedicated to building the innovative longevity biotechnology ecosystem enabling technologies that can help our customers and our network of longevity physicians. One of the main breakthroughs of the past decade is the invention of the so-called aging clocks, biomarkers of aging that allow us to measure the rate of aging and evaluate the effectiveness of the various interventions. ETP Ventures and HLPIVF are investing in Deep Longevity because of their proven technology leadership in the development of AI-based aging clocks using many data types. These clocks will be available in the near future to our scientists, physicians, and our customers.”

About Deep Longevity, Inc
Deep Longevity is a global leader in deep learning for aging research specializing in the development of deep biomarkers of aging using clinical blood tests, transcriptomic, proteomic, epigenetic, microbiome, behavioral, wearable, imaging, and multiple other data types. The company holds exclusive licenses to a comprehensive IP portfolio including both granted and pending patents. The company provides a broad range of deep aging clocks to some of the world’s most advanced longevity clinics and physicians and is developing a range of simple consumer applications to track the rate of aging at the individual level. The company is developing a comprehensive decision support system for physicians to enable the development of personalized longevity protocols utilizing the latest advances in longevity biotechnology. www.DeepLongevity.com

About Human Longevity, Inc.
Human Longevity, Inc. is a genomics-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI’s business focus includes the Health Nucleus, a genomic-powered, precision medicine center which uses whole-genome sequencing analysis, advanced imaging, and blood analytics, to deliver the most complete picture of individual health. For more information, visit www.humanlongevity.com.

About Human Longevity and Performance Impact Venture Fund
Human Longevity and Performance Impact Venture Fund is a longevity focused early stage venture capital fund dedicated to providing resources, insight, and leadership to companies whose mission is to improve human health and drive longevity through technology, predictive analytics, research, and patient care. HLPIVF is establishing a synergistic ecosystem of longevity and performance focused companies to dramatically increase the volume and effectiveness of life-affirming diagnostics and therapeutics.

Epazz DeskFlex Signs Up an Average of 5 New Customers Per Week for Its Desk Booking Software, as Companies Return to the Office After COVID-19 Lockdowns

Epazz DeskFlex desk booking software receives an influx of new customers in compliance with social distancing policies

Epazz, Inc., DeskFlex (OTC: EPAZ), a mission-critical cloud computing software provider company, confirmed today that DeskFlex desk booking software is signing up about five new customers per week. The company receives strong interest from enterprises, governments, nonprofits, and hospitals. This increase in sales will be seen in the third quarter financials.

DeskFlex meeting room booking software continuously adds new features and functions that help public and private organizations, schools, and enterprises transition to the “new normal” during the COVID-19 pandemic. DeskFlex meeting room scheduling software recently added COVID-compliant features, including the Thermal Scanner, Mask Detection, Social Distancing Survey, Contact Tracing, Automatic Desk Sanitation, Dynamic Scheduling, Capacity Limits, and Visitor Management.

DeskFlex helps offices and schools prevent infection within the vicinity. DeskFlex’s room scheduling system can also quickly facilitate the Contact Tracing process in case of an outbreak. The complementary devices – such as Contactless Room Display, the FlexCube, Bluetooth Beacons, and the Lobby Kiosks – assist in the software’s functionality.

Since June, DeskFlex has received subsequent requests for product demonstrations and software training as well as increased subscriptions. The DeskFlex room booking system ensures that their software features and hardware components comply with COVID-19 measures required by health departments around the world. DeskFlex desk booking software anticipates a rising trend for an interactive business software solution that secures employee health and safety.

Founded in 1997, DeskFlex is a pioneer in desk booking software, conference room booking, and remote working concepts. For over 20 years, DeskFlex continually improves to meet the demands and challenges of various organizations in a different era.

According to Shaun Passley, PhD, CEO of Epazz, Inc., “We are gratified to announce that our team is now working overtime to cater to different organizations that request customized DeskFlex anti-COVID features and help them return to work or back to school safely.”

About DeskFlex.com
DeskFlex is a desk booking solution and room reservation software for conference rooms, workspaces, desks, car parking spaces, equipment, hoteling, and HotDesking that helps office managers accommodate the occasional needs of mobile workers while reducing rent and facility costs. DeskFlex lets employees reserve space in advance or claim desks right away. It adjusts the telephone switch (PBX) so calls ring at the “desk du jour.” DeskFlex includes check-in, point-and-click floor maps, a web browser, a local kiosk, Outlook integration, and conference room scheduling.

About Epazz, Inc. (www.epazz.com)
Epazz, Inc., is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher education institutions, and the public sector. Epazz BoxesOS(TM) v3.0 is a complete web-based software package for small- to mid-size businesses, Fortune 500 enterprises, government agencies, and higher education institutions. BoxesOS(TM) provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz’s other products are K9Sky kennel software and the Provitrac applicant tracking system.

SAFE HARBOR
This is the Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by the use of forward-looking words such as “may,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” and “continue” (or the negation thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from future results or those implied by such forward-looking statements. Investors are cautioned that no forward-looking statement is a guarantee of future performance and that actual results may differ materially from those contemplated by such forward-looking statements. Epazz, Inc., assumes no obligation and has no intention of updating these forward-looking statements. It has no obligation to update or correct information prepared by third parties that are not paid for by Epazz, Inc. Investors are encouraged to review Epazz, Inc.’s, public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC market filings, which contain general business information about the company’s operations, results of operations, and risks associated with the company and its operations.

CONTACT
For more information, please contact
Investor Relations
investors@epazz.net
(312) 955-8161
www.epazz.com